HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuromuscular symptoms in a patient with familial pseudohypoparathyroidism type Ib diagnosed by methylation-specific multiplex ligation-dependent probe amplification.

Abstract
Pseudohypoparathyroidism type Ib (PHP-Ib) is a rare genetic disorder characterized by hypocalcemia and hyperphosphatemia due to imprinting defects in the maternally derived GNAS allele. Patients with PHP-Ib are usually identified by tetany, convulsions, and/or muscle cramps, whereas a substantial fraction of patients remain asymptomatic and are identified by familial studies. Although previous studies on patients with primary hypoparathyroidism have indicated that hypocalcemia can be associated with various neuromuscular abnormalities, such clinical features have been rarely described in patients with PHP-Ib. Here, we report a 12-year-old male patient with familial PHP-Ib and unique neuromuscular symptoms. The patient presented with general fatigue, steppage gait, and myalgia. Physical examinations revealed muscular weakness and atrophies in the lower legs, a shortening of the bilateral Achilles' tendons and absence of deep tendon reflexes. Laboratory tests showed hypocalcemia, hyperphosphatemia, elevated serum intact PTH level, and impaired responses of urinary phosphate and cyclic AMP in an Ellsworth-Howard test, in addition to an elevated serum creatine kinase level. Clinical features of the patient were significantly improved after 1 month of treatment with alfacalcidol and calcium. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) and subsequent PCR analyses identified a methylation defect at exon A/B of GNAS and a microdeletion involving exons 4-6 of the GNAS neighboring gene STX16 in the patient and in his asymptomatic brother. The results suggest that various neuromuscular features probably associated with hypocalcemia can be the first symptoms of PHP-Ib, and that MS-MLPA serves as a powerful tool for screening of GNAS abnormalities in patients with atypical manifestations.
AuthorsKeisuke Nagasaki, Shuichi Tsuchiya, Akihiko Saitoh, Tsutomu Ogata, Maki Fukami
JournalEndocrine journal (Endocr J) Vol. 60 Issue 2 Pg. 231-6 ( 2013) ISSN: 1348-4540 [Electronic] Japan
PMID23095209 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Calcium, Dietary
  • Chromogranins
  • Hydroxycholecalciferols
  • STX16 protein, human
  • Syntaxin 16
  • GNAS protein, human
  • GTP-Binding Protein alpha Subunits, Gs
  • alfacalcidol
Topics
  • Calcium, Dietary (therapeutic use)
  • Child
  • Chromogranins
  • DNA Methylation
  • Dietary Supplements
  • Exons
  • Family Health
  • Fatigue (etiology)
  • GTP-Binding Protein alpha Subunits, Gs (genetics, metabolism)
  • Gait Disorders, Neurologic (etiology, prevention & control)
  • Gene Deletion
  • Humans
  • Hydroxycholecalciferols (therapeutic use)
  • Hypocalcemia (etiology, physiopathology, prevention & control)
  • Male
  • Multiplex Polymerase Chain Reaction
  • Musculoskeletal Pain (etiology, prevention & control)
  • Neuromuscular Diseases (etiology, prevention & control)
  • Pseudohypoparathyroidism (blood, diet therapy, genetics, physiopathology)
  • Syntaxin 16 (genetics, metabolism)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: